NCT04249284View on ClinicalTrials.gov

Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 6, 2020

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Specified dose on specified days

DRUG

BMS-986165 prototype 1

Specified dose on specified days

DRUG

BMS-986165 prototype 2

Specified dose on specified days

Trial Locations (1)

33126

Quotient Sciences Miami, Miami

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04249284 - Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants | Biotech Hunter | Biotech Hunter